Je dividenda Fagron bezpečná?
Fagron zvyšuje dividendu už 3 rokov.
V priebehu posledných 10 rokov Fagron ročne -7,708 % znížené.
Na 5-ročnú perspektívu vzrástol výplata o 20,112 %.
Analytici očakávajú pre bežný obchodný rok nárast o Rast dividend vo výške 6,667%.
Fagron Aktienanalyse
Čo robí Fagron?
Fagron NV is an internationally operating company that focuses on the development and production of customized medications for pharmacies and hospitals. The company was founded in 1990 in Rotterdam, Netherlands.
The beginnings of Fagron NV were in the Netherlands, where the company was established as Roterodamum Chemie BV. In the late 1990s, the company was converted into a holding company called Arseus NV, which later received the name Fagron. In 2012, Fagron was listed on the Euronext stock exchange in Brussels.
Fagron operates globally and has locations in Europe, North America, Latin America, the United Arab Emirates, Asia, and Australia.
Fagron's business model is based on the production of specialized medications for individual patient needs. The company offers a wide range of pharmaceutical active ingredients, raw materials, and processing services. There is also the possibility to develop and manufacture customized formulations tailored to the needs of patients. Fagron not only manufactures customized medications but also provides training and support for pharmacies and hospitals.
Fagron operates in three main divisions: Specialty Pharma (hospital care), Community Pharma (prescription and non-prescription medications), and Compounding Services (custom formulations).
The Specialty Pharma division specializes in medications for use in hospitals. It offers a wide range of products that can be used in the treatment of conditions such as cancer, HIV, and tuberculosis. These medications are manufactured in various dosage forms, such as injections, infusions, and tablets.
The Community Pharma division focuses on prescription and non-prescription medications. Both branded and generic medications are offered. These are delivered directly to pharmacies, hospitals, and clinics.
The Compounding Services division specializes in the production of customized medications. Fagron works closely with pharmacies and hospitals to meet individual needs. This includes, for example, the manufacture of medications in specific dosages or the combination of several active ingredients in a custom formulation.
Fagron offers a wide range of products, including hormones, pain medications, cancer drugs, medications for the treatment of skin diseases, ophthalmic products, and anti-infectives. Pharmaceutical active ingredients and raw materials are also offered.
Overall, Fagron is a global leader in the production of customized medications. It has extensive experience and expertise in the manufacturing of pharmaceutical formulations and offers a wide range of products and services. The various divisions of Fagron allow the company to meet the diverse needs of its customers and maintain its position as a leading company in the pharmaceutical industry. Fagron je jednou z najobľúbenejších spoločností na Eulerpool.com.Investičné plány do akcií ponúkajú atraktívnu možnosť pre investorov na dlhodobú výstavbu majetku. Jednou z hlavných výhod je tzv. Cost-Average-Effekt: Pravidelnou investíciou pevnej sumy do akcií alebo do akciových fondov automaticky kupujete viac podielov, keď sú ceny nízke, a menej, keď sú vysoké. To môže viesť k výhodnejšej priemernej cene za podiel v priebehu času. Okrem toho investičné plány do akcií umožňujú aj malým investorom prístup k drahým akciám, keďže sa dá investovať už s malými sumami. Pravidelná investícia tiež podporuje disciplinovanú investičnú stratégiu a pomáha predchádzať emocionálnym rozhodnutiam, ako je impulzívne kupovanie alebo predávanie. Ďalej investorom prináša potenciálny nárast hodnoty akcií, ako aj výplaty dividend, ktoré môžu byť reinvestované, čo zvyšuje efekt zloženého úroku a tým rast investovaného kapitálu.